FUT2 and allergic disease: Higher concentrations of FUT2-dependent HMOs such as 2′-fucosyllactose were also correlated with lower risk of allergy at 2 and 5 y of age in infants with high hereditary allergy risk (45), and HMOs including 2′-fucosyllactose attenuated food allergy symptoms in a mouse model (46).